Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.37 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123180 | 0.82 | TSHR (0.48) | ALDH1A1CYP2A6TSHRHSD17B10TDP1 | |
| SCHEMBL30618856 | 0.79 | BACE1 (0.43) | BACE1ALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL31177892 | 0.79 | MEN1 (0.48) | BACE1ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL548462 | 0.79 | MEN1 (0.48) | BACE1ALDH1A1CYP2A6TSHRTDP1 | |
| SCHEMBL2354617 | 0.79 | BACE1 (0.43) | BACE1ALDH1A1CYP2A6TSHRHSD17B10 | |
| SCHEMBL25302086 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CYP2A6TSHRHSD17B10TDP1 | |
| SCHEMBL27953 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CYP2A6TSHRHSD17B10TDP1 | |
| SCHEMBL29350007 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CYP2A6TSHRHSD17B10TDP1 | |
| SCHEMBL6077039 | 0.77 | ALDH1A1 (0.56) | ALDH1A1CYP2A6TSHRHSD17B10TDP1 | |
| Bromide SCHEMBL7106161 | 0.77 | ALDH1A1 (0.56) | ALDH1A1CYP2A6TSHRHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131655-B1 | METHOD FOR THE QUANTIFICATION OF PARASITE EGGS IN FECES | MEP Equine Solutions LLC (US) | 2020-12-02 | — | — | EP | claimed |
| EP-2404550-B1 | Systems and methods of 4D electromagnetic tomographic (EMT) differential (dynamic) fused imaging | EMIMAGING LTD (GB) | 2015-11-11 | — | — | EP | claimed |
| CN-111201328-B | Detection of recombinant enzyme polymerase amplification using double hapten probes | 雅培诊断产品士嘉堡公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118086454-A | Method for detecting dephosphorylation activity of T4 polynucleotide kinase 3' end, probe set and kit | 深圳市真迈生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-111527257-B | Fabric treatment composition and method | HBI品牌服饰企业有限公司 | 2022-01-28 | — | — | CN | disclosed |
| US-20210275806-A1 | CATHETER SYSTEMS | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. | 2021-09-09 | — | — | US | disclosed |
| US-11000684-B2 | Catheter systems | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. (US) | 2021-05-11 | — | — | US | disclosed |
| CN-112384808-A | Methods for mitigating drug target interference in anti-drug antibody (ADA) immunoassays | 里珍纳龙药品有限公司 | 2021-02-19 | — | — | CN | disclosed |
| US-20200269038-A1 | CATHETER SYSTEMS | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. | 2020-08-27 | — | — | US | disclosed |
| CN-111527257-A | Fabric treatment composition and method | HBI品牌服饰企业有限公司 | 2020-08-11 | — | — | CN | disclosed |
| US-10688300-B2 | Catheter systems | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. (US) | 2020-06-23 | — | — | US | disclosed |
| US-9289606-B2 | System for electroporation therapy | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. (US) | 2016-03-22 | — | — | US | disclosed |
| EP-2425871-B1 | Catheter systems | ST JUDE MEDICAL ATRIAL FIBRILL (US) | 2015-09-02 | — | — | EP | disclosed |
| US-20120059255-A1 | CATHETER SYSTEMS | ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC. | 2012-03-08 | — | — | US | disclosed |
| EP-2425871-A2 | Catheter systems | St. Jude Medical, Atrial Fibrillation Division, Inc. (US) | 2012-03-07 | — | — | EP | disclosed |
| US-8129532-B2 | Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use | THE UNIVERSITY OF CONNECTICUT (US) | 2012-03-06 | — | — | US | disclosed |
| US-20090042227-A1 | AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-02-12 | — | — | US | disclosed |
| EP-1026222-B1 | Organic material for electroluminescent device and electroluminescent device using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2002-09-18 | — | — | EP | disclosed |
| US-6391482-B1 | 4,4,8,8-TETRAKIS(1H-PYRAZOL-1-YL)PYRAZABOLE; HIGH SPEED RESPONSE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-05-21 | — | — | US | disclosed |
| EP-1026222-A2 | Organic material for electroluminescent device and electroluminescent device using the same | Matsushita Electric Industrial Co., Ltd. (JP) | 2000-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042227-A1 | AMINO(OLIGO)THIOPHENE DYES, PREPARATION THEREOF, AND OPTICAL METHODS OF USE | NLN, NME4, OAT | BACE1 4401/4885ALDH1A1 4559/4885CYP2A6 4007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.